sle

Documents about sle

• ACE1831 in Adult Subjects With Relapsed/Refractory Systemic Lupus Erythematosus （SLE）#1451863ClinicalTrials.gov
• Acthar SLE (Systemic Lupus Erythematosus)#839253ClinicalTrials.gov
• OMERACT SLE Delphi#1397304ClinicalTrials.gov
• UC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) Patients#838628ClinicalTrials.gov
• MB-CART19.1 in Refractory SLE#839427ClinicalTrials.gov
• Effect of Gender on Clinical Presentation of SLE ِAt Assiut University Hospitals#1086776ClinicalTrials.gov
• KN5501 Cell Injection for Refractory SLE(CLEAR)#1261128ClinicalTrials.gov
• Effect Of Curcuma Xanthorrhiza and Vitamin D3 Supplementation in SLE Patients With Hypovitamin D#1260012ClinicalTrials.gov
• A Study of CD19 Redirected Autologous T Cells for CD19 Positive Systemic Lupus Erythematosus (SLE)#842983ClinicalTrials.gov
• An Ascending Dose Study of PIT565 in Participants With Systemic Lupus Erythematosus (SLE).#886294ClinicalTrials.gov
• Does Belimumab Modify the Natural History of SLE? A Propensity Score-matched, Real-world Study#1045555ClinicalTrials.gov
• Phase 1b/2a in SLE With Budoputug#894260ClinicalTrials.gov
• Study of AC0058TA in Patients With Systemic Lupus Erythematosus (SLE)#1030245ClinicalTrials.gov
• Role of DcR3 in T Cell Activation in SLE and RA#1419179ClinicalTrials.gov
• Efficacy of Vitamin C Supplementation on Malondialdehid Levels and Disease Activity in SLE Patients#905017ClinicalTrials.gov
• Anti-CD20 Antibodies for Treatment of SLE-PAH#651173ClinicalTrials.gov
• Improving the Assessment of SLE Disease Activity#1431752ClinicalTrials.gov
• BCMA-CD19 cCAR T Cell Treatment of Relapsed/Refractory Systemic Lupus Erythematosus (SLE)#1364660ClinicalTrials.gov
• A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE)#872224ClinicalTrials.gov
• Team-based Implementation of Hypertension Management in Childhood Lupus#1454759ClinicalTrials.gov
• Efficacy of Vitamin C Supplementation on Serum TNF-α Levels and Disease Activity in SLE Patients#1422013ClinicalTrials.gov
• Phase 1b/2a Study to Evaluate Safety and Efficacy of KPG-818 in SLE#1047047ClinicalTrials.gov
• Cyclophosphamide and Hydroxychloroquine for Thrombocytopenia in SLE#1195686ClinicalTrials.gov
• Low-dose IL-2( Interleukin-2) Treatment in SLE#1262092ClinicalTrials.gov
• Phase 1 Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE)#804106ClinicalTrials.gov
• Does Balnotherapy Influence the Qualitiy of Life in SLE#901944ClinicalTrials.gov
• European LUpuS Inception-Cohort Developing initiATivE#904158ClinicalTrials.gov
• Prospective Study of Rapamycin for the Treatment of SLE#1463999ClinicalTrials.gov
• Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)#1438232ClinicalTrials.gov
• Abatacept in the Treatment and Prevention of Active Systemic Lupus Erythematosus (SLE) Flares in Combination With Prednisone#1086944ClinicalTrials.gov
• A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)#876103ClinicalTrials.gov
• Decoy Receptor 3 (DcR3) Polymorphisms in Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE)#1383605ClinicalTrials.gov
• Effects of Nigella Sativa on T Cells and Cytokine Profile in Pediatric SLE Patients#1484118ClinicalTrials.gov
• Pharmacokinetics Study of Epratuzumab in Systemic Lupus Erythematosus (SLE)#1486809ClinicalTrials.gov
• EG-501 for Cognitive Impairment in Neuropsychiatric SLE (NPSLE): Efficacy and Safety Study#839041ClinicalTrials.gov
• Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE)#847414ClinicalTrials.gov
• Clinical Study to Investigate the Safety, Tolerability, and Pharmacokinetics of GR1603 in SLE#1409221ClinicalTrials.gov
• Alnuctamab for Refractory SLE (LATTE Study)#1486920ClinicalTrials.gov
• Phase 2 Study of Belimumab Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus (SLE)#833848ClinicalTrials.gov
• The Effect of Vitamin D Supplementation on Disease Activity Markers in Systemic Lupus Erythematosus (SLE)#839404ClinicalTrials.gov
• Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine#1075467ClinicalTrials.gov
• Auto-immunity in Lupus Patients After Influenza Vaccine#1385402ClinicalTrials.gov
• Myocardial Inflammation in Systemic Lupus Erythematosus#846153ClinicalTrials.gov
• Anifrolumab Pregnancy Study#895974ClinicalTrials.gov
• Evaluation of Type I IFN Level and Disease Activity in SLE Patients#880366ClinicalTrials.gov
• Study During Pregnancy of Expression of miRNAs in RA or SLE#915413ClinicalTrials.gov
• Maxillary Reconstruction Timing in Severe Systemic Lupus Erythematous (SLE) Patient with Bone Destruction due to Invasive Aspergillosis: Case Report#930427Acta Interna: The Journal of Internal Medicine
• The Effect of Curcumin on the Clinical Outcome of Pediatric Patients with Active Lupus Nephritis#1230252ClinicalTrials.gov
• Clinical Trial of CD19 Targeted CAR-T Cell in Refractory Adult SLE#1320570ClinicalTrials.gov
• Pediatric Lupus Trial of Belimumab Plus Background Standard Therapy#1431530ClinicalTrials.gov